MarginsXMarginsX
Home › Data Desk › Insider buying at Orchestra BioMed Holdings Inc.: 5 buyers, $6.2M

MarginsX Data Desk · Insider buying · Late-stage clinical trials · Medical devices · Public offerings

Insider buying at Orchestra BioMed Holdings Inc.: 5 buyers, $6.2M

Between Nov 9, 2026 and Nov 9, 2026, 5 insiders of Orchestra BioMed Holdings Inc. (OBIO) bought $6.2M of its shares in the open market, by their SEC filings. (SEC EDGAR, Form 4, Nov 9, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 13, 2026.

Line chart of Orchestra BioMed Holdings Inc. (OBIO) daily closes from Jul 6, 2026 to Nov 12, 2026, with the insider trades on Nov 13, 2026 marked.

The trades

Rtw Investments, LP (ten-percent owner) bought 1.2 million shares at $5.00 on Nov 9, 2026, worth $6.0M. (SEC EDGAR, Form 4, Nov 12, 2026)

Fain Eric S (director) bought 20,000 shares at $5.00 on Nov 9, 2026, worth $100K. (SEC EDGAR, Form 4, Nov 9, 2026)

Pacitti David (director) bought 20,000 shares at $5.00 on Nov 9, 2026, worth $100K. (SEC EDGAR, Form 4, Nov 9, 2026)

Hochman David P (See Remarks, director) bought 5,000 shares at $5.00 on Nov 9, 2026, worth $25K. (SEC EDGAR, Form 4, Nov 9, 2026)

Taylor Andrew Lawrence (CFO) bought 1,000 shares at $5.00 on Nov 9, 2026, worth $5.0K. (SEC EDGAR, Form 4, Nov 9, 2026)

The past year

Open-market purchases in the SEC insider data sets come to $280K over the twelve months through Sep 30, 2026, from 4 buyers. (SEC insider transactions data sets (open-market trades), Sep 30, 2026)

Open-market sales over the same months come to $258K, from 2 sellers. (SEC insider transactions data sets (open-market trades), Sep 30, 2026)

The stock

The Nasdaq screener puts its market value at $484.0M. (Nasdaq stock screener, Nov 13, 2026)

Orchestra BioMed Holdings Inc. has about 5.3 months of cash at its recent burn

The 10-Q that Orchestra BioMed Holdings Inc. (OBIO) filed on Nov 10, 2026 covers the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 10, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/OBIO)

The filing on SEC EDGAR. (sec.gov)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameOrchestra BioMed Holdings Inc.Source2026-11-13
Insiders5Source2026-11-09
InsiderRtw Investments, LPSource2026-11-12
InsiderFain Eric SSource2026-11-09
InsiderPacitti DavidSource2026-11-09
InsiderHochman David PSource2026-11-09
InsiderTaylor Andrew LawrenceSource2026-11-09
Total6,230,000 USDSource2026-11-09
Value6,000,000 USDSource2026-11-12
Value100,000 USDSource2026-11-09
Value25,000 USDSource2026-11-09
Value5,000 USDSource2026-11-09
FirstNov 9, 2026Source2026-11-09
LastNov 9, 2026Source2026-11-09
WhoOrchestra BioMed Holdings Inc. (OBIO)Source2026-11-13
SymbolOBIOSource2026-11-13
Titleten-percent ownerSource2026-11-12
Shares1,200,000 sharesSource2026-11-12
Price5 USDSource2026-11-12
Trade dateNov 9, 2026Source2026-11-12
TitledirectorSource2026-11-09
Shares20,000 sharesSource2026-11-09
TitleSee Remarks, directorSource2026-11-09
Shares5,000 sharesSource2026-11-09
TitleCFOSource2026-11-09
Shares1,000 sharesSource2026-11-09
Buy 12m279,890.65 USDSource2026-09-30
ThroughSep 30, 2026Source2026-09-30
Buyers 12m4Source2026-09-30
Sell 12m257,682.16 USDSource2026-09-30
Sellers 12m2Source2026-09-30
Cap484,035,486 USDSource2026-11-13
Form10-QSource2026-11-10
FiledNov 10, 2026Source2026-11-10
Period endSep 30, 2026Source2026-11-10

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS